In order to strengthen Lytix Biopharma`s research program on Oncolytic peptides, the company is collaborating with the international leading experts.
Guido Kroemer and Laurence Zitvogel, Institute Gustav Roussy, have been central in the discovery of apoptosis, immunogenic cell death and role of the microbioma in cancer treatment.
Joost Oppenheim, National Cancer Institute CI,pioneered the development of cytokine and chemokine fields of research and is currently studying the role of alarmins that activate toll-like receptors.
Sandra Demaria, Weill Cornell Medical College, New York,has been central in understanding how radiation modulates tumor immunogenicity and improves response to immunotherapy.
Mikael Pittet, Harvard Medical School, Boston, studies cellular network dynamics and employs three-dimensional bioimaging technologies to analyze their role in health and disease.